Article View: be.science
Article #415Cancer - Press Review (August 18, 2012) – Revue de presse (18 août 2012)
From: SMW
Date: Sat, 18 Aug 2012 18:51
Date: Sat, 18 Aug 2012 18:51
102 lines
5873 bytes
5873 bytes
Cancer – Press Review – Revue de Presse Every week on http://marclacroixcancerblog.blogspot.com Chaque semaine sur http://marclacroixcancerblog.blogspot.com Press Review (August 18, 2012) – Revue de presse (18 août 2012) An Aspirin a Day May Still Lower Cancer Risk, but Not as Much as Previously Thought A new study offers fresh evidence that popping a daily aspirin is associated with a lower risk of dying from cancer, but the size of the potential protective effect may be smaller than previous research has suggested By Alexandra Sifferlin. In TIME http://healthland.time.com/2012/08/10/an-aspirin-a-day-may-still-lower-cancer-risk-but-not-as-much-as-previously-thought/ Radiation after lumpectomy helps prevent need for mastectomy in early stage breast cancer Contrary to clinical recommendations, older women with early stage breast cancer may want to undergo radiation after lumpectomy to help ensure that they will not need a mastectomy in the future. That is the conclusion of a new study published early online in CANCER, a peer- reviewed journal of the American Cancer Society. The findings indicate that current thinking on the risks and benefits of radiation for early stage breast cancer in older women may be inaccurate. In Science Codex http://www.sciencecodex.com/radiation_after_lumpectomy_helps_prevent_need_for_mastectomy_in_early_stage_breast_cancer-96414 Early Breast Cancer in Older Women: Mastectomies Avoidable for Some A study published in Cancer, the journal of the American Cancer Society, provides evidence that older women with early-stage breast cancer who undergo radiation therapy following a lumpectomy are less likely to require a subsequent mastectomy. This is contrary to current recommendations that suggest radiation therapy does not play a role in determining whether an older woman will need a mastectomy following a lumpectomy for her early-stage breast cancer. The authors suggest the current recommendations are based on inaccurate thinking of the risks and benefits of radiation therapy. By Anna Azvolinsky. In Cancer Network http://www.cancernetwork.com/breast-cancer/content/article/10165/2096869 Komen's Leadership Changes Are Met With Skepticism Leadership changes at the Susan G. Komen Foundation for the Cure six months after an online uproar over a decision to cut funds for breast cancer screenings at Planned Parenthood was greeted with skepticism on Thursday among breast cancer advocates and longtime former supporters. By Jennifer Preston. In New York Times (blog) http://thelede.blogs.nytimes.com/2012/08/09/komens-leadership-changes-are-met-with-skepticism/ Screening Debate Typifies Prostate Cancer Uncertainties Experts differ, leaving men with no easy answers. By Serena Gordon. In U.S. News & World Report http://health.usnews.com/health-news/news/articles/2012/08/10/screening-debate-typifies-prostate-cancer-uncertainties La surcharge pondérale favorise (aussi) les seconds cancers Combattre le surpoids permet de réduire le risque de développer une deuxième tumeur, voire un premier cancer du sein. Par Anne Jeanblanc. Dans Le Point http://www.lepoint.fr/chroniqueurs-du-point/anne-jeanblanc/la-surcharge-ponderale-favorise-aussi-les-seconds-cancers-13-08-2012-1495564_57.php Cancer du sein: médicament de Roche homologué en Suisse L'homologation se fonde sur les résultats d'une étude qui a montré que les patientes ayant reçu le traitement combiné par Perjeta ont vécu en moyenne six mois de plus sans aggravation de leur tumeur cancéreuse. Dans 24heures.ch http://www.24heures.ch/sante/sante/Cancer-du-sein-medicament-de-Roche-homologue-en-Suisse/story/11038063 Un cachet d'aspirine par jour réduit les risques de mourir d'un cancer Selon les chercheurs, le risque serait diminué de 16%. Dans Atlantico.fr http://www.atlantico.fr/pepites/cachet-aspirine-jour-reduit-risque-cancer-449244.html Cancer Blog – Marc Lacroix – Le Blogue du Cancer http://marclacroixcancerblog.blogspot.com
Technical Details
Message-ID:
<0df6f412-b2c2-44e4-b20a-e30e968b4c42@l7g2000vby.googlegroups.com>Path:
arc1-ca.pugleaf.net!p10ni98095471pbh.1!nntp.google.com!npeer02.iad.highwinds-media.com!news.highwinds-media.com!feed-me.highwinds-media.com!postnews.google.com!l7g2000vby.googlegroups.com!not-for-mailShow Full Headers
Complete Article Headers
X-Google-Thread: f5500,eae440e0e2147933,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.68.136.71 with SMTP id py7mr1442945pbb.4.1345315872792;
Sat, 18 Aug 2012 11:51:12 -0700 (PDT)
Path: arc1-ca.pugleaf.net!p10ni98095471pbh.1!nntp.google.com!npeer02.iad.highwinds-media.com!news.highwinds-media.com!feed-me.highwinds-media.com!postnews.google.com!l7g2000vby.googlegroups.com!not-for-mail
From: SMW <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press Review (August 18, 2012) – Revue de presse (18 août 2012)
Date: Sat, 18 Aug 2012 11:51:12 -0700 (PDT)
Organization: http://groups.google.com
Lines: 104
Message-ID: <0df6f412-b2c2-44e4-b20a-e30e968b4c42@l7g2000vby.googlegroups.com>
NNTP-Posting-Host: 81.247.105.225
Mime-Version: 1.0
X-Trace: posting.google.com 1345315872 6517 127.0.0.1 (18 Aug 2012 18:51:12 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 18 Aug 2012 18:51:12 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: l7g2000vby.googlegroups.com; posting-host=81.247.105.225; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/537.1 (KHTML, like
Gecko) Chrome/21.0.1180.79 Safari/537.1,gzip(gfe)
X-Received-Bytes: 5492
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable